Drug: SERETIDE Injury: Exposure during pregnancy Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125320171 | SERETIDE | Exposure during pregnancy | GLAXOSMITHKLINE | 43.55 YR | F | 0 | 20160706 | CH |
125420201 | SERETIDE | Exposure during pregnancy | SANDOZ | 43.00 YR | F | 0 | 20160708 | CH |
125524001 | SERETIDE | Exposure during pregnancy | APOTEX | 43.00 YR | F | 0 | 20160713 | GB |
126147783 | SERETIDE | Exposure during pregnancy | GLAXOSMITHKLINE | 30.86 YR | F | 0 | 20160823 | JP |
126295991 | SERETIDE | Exposure during pregnancy | GLAXOSMITHKLINE | 0.00 | F | 0 | 20160808 | JP |
127498421 | SERETIDE | Exposure during pregnancy | GLAXOSMITHKLINE | 28.00 YR | F | 0 | 20160916 | JP |
Total Records: 6 Number of Pages: 1